CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma

发表于 2026-8-16 09:38:38

期刊：Cancer Letters

文献作者：Feifan Yao; Suiqing Zhou; Ruizhi Zhang; Yining Chen; Wei Huang; Kai Yu; Nanmu Yang; Xiangjun Qian; Xiaofeng Tie; Jiali Xu; Yu Zhang; Tasiken Baheti; Jing Xu; Xinzheng Dai; Xiaopei Hao; Liren Zhang; Xuehao Wang; Qing Li

出版日期：2024-7-

DOI号：10.1016/j.canlet.2024.216935

下载链接：https://www.sciencedirect.com/sc ... 304383524003288/pdf

文献链接：https://doi.org/10.1016/j.canlet.2024.216935

当前文献来源于 Elsevier BV。

备注信息：

发表于 2026-8-16 09:38:39

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Elsevier/Sciencedirect] CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Elsevier/Sciencedirect] CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma 一键复制